tetraethylammonium has been researched along with Hemiplegia in 1 studies
Tetraethylammonium: A potassium-selective ion channel blocker. (From J Gen Phys 1994;104(1):173-90)
Hemiplegia: Severe or complete loss of motor function on one side of the body. This condition is usually caused by BRAIN DISEASES that are localized to the cerebral hemisphere opposite to the side of weakness. Less frequently, BRAIN STEM lesions; cervical SPINAL CORD DISEASES; PERIPHERAL NERVOUS SYSTEM DISEASES; and other conditions may manifest as hemiplegia. The term hemiparesis (see PARESIS) refers to mild to moderate weakness involving one side of the body.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
OKINAKA, S | 1 |
NAKAMURA, H | 1 |
TSUBAKI, T | 1 |
KUROIWA, Y | 1 |
TOYOKURA, Y | 1 |
1 other study available for tetraethylammonium and Hemiplegia
Article | Year |
---|---|
A contribution to the study of pathogenesis of the pupillary changes in severe cerebral apoplexy and in chronic hemiplegia. A. Clinico-pathological studies on anisocoria in severe apoplexy attack. B. Clinico-pathological studies on anisocoria in chronic h
Topics: Animals; Anisocoria; Behavior, Animal; Cerebral Hemorrhage; Hemiplegia; Humans; Pupil; Pupil Disorde | 1953 |